Pacira BioSciences Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$192,399	$177,376	$196,873	$179,516
Gross Profit	148,235	140,963	156,574	145,238
EBITDA	25,596	29,507	25,285	34,368
EBIT	4,301	8,176	3,943	13,177
Net Income	4,653	2,916	1,637	5,432
Net Change In Cash	192,399	177,376	196,873	179,516
Free Cash Flow	56,124	22,956	43,471	56,964
Cash	205,875	144,306	158,545	147,589
Basic Shares	40,300	40,910	42,981	44,459

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$726,411	$700,966	$674,978	$666,823
Gross Profit	576,662	530,538	490,309	467,528
EBITDA	122,503	29,118	154,585	140,379
EBIT	31,480	-49,667	79,011	48,878
Net Income	7,034	-99,560	41,955	15,909
Net Change In Cash	726,411	700,966	674,978	666,823
Free Cash Flow	136,661	178,753	139,488	115,198
Cash	158,545	276,774	153,298	104,139
Basic Shares	45,042	46,245	51,979	46,538